[1]Wang,Qi;Dai,Yang;Ji,Yinchun;Shi,Huanyu;Guo,Zuhao;Chen,Danqi;Chen,Yuelei;Peng,Xia;Gao,Yinglei;Wang,Xin;Chen,Lin;Jiang,Yuchen;Geng,Meiyu;Shen,Jingkang;Ai,Jing;Xiong,Bing[EuropeanJournalofMedicinalChemistry,2019,vol.163,p.671-689]
1233526-47-0
1233526-60-7
877399-74-1
847818-72-8
827614-66-4
827614-69-7
1326715-94-9 | 1-Boc-pyrrolo[2,3-c]pyridine-3-ylboronic acid | AA0010VT | MFCD13189529
132866-11-6 | Lercanidipine Hydrochloride | AA00117N | MFCD09265254
13301-04-7 | Methyl 3,6-dibromopyrazine-2-carboxylate | AA0011GR | MFCD11976863
1363383-37-2 | 4-(Boc-amino)-2-hydroxypyridine | AA0011OO | MFCD17214400
1365272-21-4 | 1-Bromo-2-ethoxy-5-fluoro-3-nitrobenzene | AA0011WM | MFCD21609502
13669-57-3 | 3-Bromoquinolin-6-ol | AA00125A | MFCD18260430
136888-20-5 | 5-Fluoro-3-nitropyridin-2-ol | AA0012G0 | MFCD05662412
13709-36-9 | Xenon fluoride (XeF2) | AA0012RQ | MFCD00040538
1373233-47-6 | t-Butyl N-[3-(propane-1-sulfonyl)phenyl]carbamate | AA00132H | MFCD22192555
1375069-20-7 | 5-[4-Fluoro-3-(trifluoromethyl)phenyl]-2-methoxypyridine | AA0013CV | MFCD22205809